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Abstract
Nonsurgical aesthetic procedures continue to grow in popularity; however, evidencebased clinical practice guidelines that can assist providers when performing aesthetic
treatments are lacking. This gap in practice can result in the increased prevalence of side
effects from treatments that can compromise patient safety and result in increased
litigation. The goal of this project was the development of a clinical practice guideline
(CPG) that can be used by aesthetic providers to standardize care when performing
nonsurgical aesthetic procedures that can ultimately improve provider knowledge, which
would improve patient safety. This CPG sought to answer the practice-focused question
involving whether the development of a CPG for aesthetic providers can increase their
knowledge about delivering safe and consistent patient care. The Appraisal of Guidelines
for Research & Evaluation (AGREE) II instrument was the guiding framework used to
develop and appraise the CPG once it was developed. Based on the AGREE II CPG
evaluation criteria, an expert review panel consisting of six professionals from the
medical spa industry analyzed the CPG using the AGREE II appraisal tool. Feedback
from the expert panel was used to modify the draft version of this CPG before completing
and presenting the final draft. The expert panel recommended the CPG for future
incorporation and use at the project site. By incorporating and using this CPG, aesthetic
treatments can be standardized to help improve patient safety, reduce adverse events, and
improve patient outcomes, which can positively impact social change at the project site as
well as practice sites locally, nationally, and globally.
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Section 1: Nature of the Project
Introduction
Options and prevalence of nonsurgical aesthetic procedures continue to rise
nationwide. With that rise, there is also an increase in the prevalence of botched
procedures by inexperienced providers and those who do not follow safety guidelines set
by state nursing and medical boards. There is also a lack of clear and up-to-date safety
and legal guidelines governing nonsurgical aesthetic procedures. Inexperienced providers
and lack of clear and concise guidelines and adherence to existing guidelines present
challenges for the med-spa industry, providers, and patients. The goal of the project was
to develop a clinical practice guideline (CPG) that can assist healthcare providers at a
local med spa to safely and effectively perform nonsurgical aesthetic procedures. This
project supports regulatory compliance, enhances provider practice, and improves patient
outcomes and safety, which ultimately improves care practices in the field of aesthetics.
In doing so, the CPG improves patient outcomes and helps prevent or reduce legal
ramifications associated with healthcare providers’ noncompliance with their respective
regulatory state licensing boards, with implications for positive social change.
Problem Statement
As advancements in nonsurgical medical aesthetics procedures continue to
evolve, state and federal policies providing clear and up-to-date safety and legal
guidelines for such procedures performed at medical spas by registered nurses (RNs),
nurse practitioners (NPs), physician assistants (PAs), and physicians are limited or
lacking. Botched procedures are being performed nationwide, resulting in irreversible
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damages such as dermal burns, scarring, and even blindness, which often result from
medical spa providers not following state guidelines (American Med Spa Association
[AMSPA], 2018). As more people come forward with complications resulting from
nonsurgical procedures performed by improperly trained providers, increased exposure
through the media has resulted. As the publics’ awareness about more cases like these
increases, state regulatory agencies have increased enforcement of state guidelines
violations (AMSPA, 2018). Many medical spas and operators have faced legal
ramifications due to a lack of proper supervision of medical treatments and improperly
trained personnel (Goldberg, 2018). Noncompliance with state and federal laws and
professional scope of practice compromise patient safety and increase litigation potential.
The Medical Board of California (MBOC) and California Board of Nursing
(CBON) require that an initial good faith exam (GFE) be performed and documented by a
physician or an APRN (advanced practice registered nurse) (AMSPA, 2018). Physicians
may delegate APRNs to perform the initial medical clearance GFE of a patient prior to
the patient undergoing an aesthetic procedure (AMSPA, 2020; MBOC, 2020). The
AMSPA (2018) said 37% of respondents to a survey related to the GFE admitted either
the GFE was not being performed or that the physician, PA, or NP was not the one
performing the initial exam. However, there are currently no guidelines for aesthetic
providers regarding specifics of the GFE, also known as the medical clearance
assessment, and postprocedural follow-up and evaluation for any future medical
treatment that may be performed (AMSPA, 2018). The common belief among aesthetic
providers is that they are complying with laws and regulations as long as they document
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and detail procedures that were performed and patient outcomes. While some providers
may admit to verbally reassessing patients before any medical procedure, this information
is not documented in formal medical charts. This is also the case at the intended project
site.
For inexperienced medical spa owners, current laws are ambiguous in terms of
what exactly constitutes physician supervision and delegation for RNs and NPs. This has
led to inconsistencies in care that have compromised patient safety and care outcomes.
This CPG improves patient and provider safety by ensuring that patients’ medical history
is reviewed prior to each aesthetic treatment and provides an easy-to-use checklist to
support the approach. This checklist allows the health care provider to know if all
necessary steps were taken prior to providing treatment or if further action is needed.
Developing a practice process that incorporates a medical history review and the
completion of a preprocedural checklist during every patient visit improves patient care,
patient safety, and nursing practice.
Purpose Statement
Through a review of literature, individual cases of wrongdoing, past and current
lack of care oversight, and inadequate training were identified in this project.
Customarily, patients receive medical clearance by their primary care physician (PCP)
before a scheduled surgery that usually includes tests like blood work and an
electrocardiogram (EKG) (Keshavan & Swamy, 2016). Although the procedures at
medical spas are considered nonsurgical, similar protocols can be established to guide
clinicians and standardize care practices. Medical spa providers must be mindful that the
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majority of medical spa procedures being performed are medical treatments and hence
should be governed by laws and regulations of standard procedures (SPs) to support
compliance with their respective scope of practice (AMSPA, 2020). While healthcare
professionals may perceive patient evaluations prior to any medical procedure as
common sense, the consistent performance of such evaluations in the medical spa
industry due to a lack of procedure protocols and/or lack of knowledge or experience
regarding procedures being performed is questionable (AMSPA, 2018). At the intended
project site, there is a lack of standardized care practice protocols that can assist staff in
providing safe patient care and compliance with current national and state regulations and
state scope of practice guidelines, resulting in a gap in practice. This DNP project was
focused on the development of a CPG that can assist practitioners in providing safe and
consistent care to reduce the practice gap. The project’s practice-focused question for this
project was: Can the development of a CPG for aesthetic providers increase their
knowledge about delivering safe and consistent patient care? The ultimate goals of
practice protocols are to provide patients with safe and standardized care, prevent
unwanted complications, and avoid legal ramifications (Adatto & Byrd, 2017). This
practice protocol can standardize care, increase provider knowledge, and improve patient
outcomes, which can positively impact patient outcomes.
Nature of the Doctoral Project
Due to limited literature about the nonsurgical aesthetic field, the AMSPA was
established to help guide medical spa organizations and clinicians. As the leading source
for policies and procedures in the medical spa industry, the AMSPA’s staff agreed to
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support the proposed clinical project by providing information that would aid in the
development of this project.
A review of literature was conducted to support the clinical practice problem and
guideline development using the Walden University Library to search various databases
(CINAHL, ERIC, MEDLINE, PubMed, and BioMed Central). Search terms included:
AGREE II, best practice, clinical practice guidelines, Melnyk and Fineout-Overholt
rating system of hierarchy of evidence, theory in aesthetics, rules and regulations,
medical spas in California, lawsuits with med spas, California med spa laws, California
Board of Nursing, California Board of Medicine, good-faith exam, trouble for med spas,
patient safety, safety in aesthetics, aesthetic dermatology, cosmetic dermatology, best
practice, physician supervision, adverse events in aesthetics, and medical procedures by
nurses. As an additional source of reference, the AMSPA provided updated information
relevant to laws and regulations of medical spas in the state of California.
This clinical practice project was focused on developing a CPG for the medical
spa facility at the project site. Approval to conduct this project at the practice site was
provided by the administrator and physician owner of the med spa. The Walden
University Manual for Clinical Practice Guideline Development was used to support this
project. I communicated with the site owner/physician, and a plan was established with
measurable and attainable goals as identified in Walden University’s CPG project
manual. The guideline was developed using The Appraisal of Guidelines for Research &
Evaluation Instrument (AGREE II), which involves developing scope and purpose,
stakeholder involvement, rigor or development, clarity of presentation, applicability, and
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editorial independence. The AGREE II gives researchers guidance on the recommended
context of a high quality CPG and has been used for many years by CPG developers. An
expert review panel was formed to review the CPG. The expert panel consisted of one
physician owner, the general manager, one PA, one NP, and two RNs. The expert panel
was educated regarding the AGREE II instrument and its use. The panel was provided 2
weeks to review the CPG and provide feedback. After review by the panel, the CPG was
scored according to AGREE II scoring instructions and revised due to panel feedback.
Evidence collected to support this CPG was organized and graded by the Melnyk
and Fineout-Overholt rating system (MFRS) of hierarchy of evidence. The MFRS is a
reference tool for researchers to grade the quality of evidence they are using to support
their proposed project development. During the development of this CPG, the latest
evidence-based literature was incorporated. The hierarchy of evidence rating systems
helped me to determine the level of evidence of literature ranging from level I –VII with
level I being of highest quality.
Significance
Stakeholders impacted by this doctoral project were the employees and the
administrator/owner of the medical spa facility located in the western region of the
United States. The facility employees impacted by this project were RNs, NPs, PAs,
general management, and one physician. The administrator and physician owner of the
medical spa supported this doctoral project. The administrator agreed that this doctoral
project when disseminated can fill the current clinical practice gap at the med spa and can
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assist employees in terms of following state guidelines. This project can improve patient
outcomes while potentially reducing the chance of legal ramifications.
Walden University (2018) defined positive social change as “a deliberate process
of creating and applying ideas, strategies, and actions to promote the worth, dignity, and
development of individuals, communities, organizations, institutions, cultures, and
societies” (para. 2). This DNP project focused on developing a CPG to streamline care in
a med spa setting and promote patient safety by reducing patient complications,
improving patient outcomes, and ultimately preventing legal ramifications. This CPG can
promote compliance with state and federal guidelines for med spa clinicians, ultimately
improving patient safety and protecting clinicians, hence promoting positive social
change. This CPG also benefits RNs, NPs, PAs, physicians, and medical spa
organizations at the local, state, and national levels, and most importantly, patients at
large.
Summary
Developing a CPG for aesthetic procedures assists clinicians in performing
standardized procedures by improving patient outcomes while protecting and enhancing
patient and clinician safety. This project can fill the gap in practice related to lack of
available guidelines for clinicians to support improving patient care outcomes and safety
during nonsurgical cosmetic procedures. As more nurses fill the needed demand for nurse
injector positions, the field of aesthetics can continue to grow. This project allows nurses
to positively impact social change through the advancement of evidence-based care. The
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project aligns with the AMSPA’s policies and procedures related to aesthetic nonsurgical
interventions in medical spas.
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Section 2: Background and Context
Introduction
In the field of nonsurgical aesthetics, procedures primarily performed at medical
spas lack clear and up-to-date guidelines on safety protocols and scope-of-practice for
RNs, nonphysician providers, and physicians. This CPG provides a tool for such
providers to have when performing nonsurgical aesthetic procedures to help improve
patient safety while ensuring compliance with state and federal guidelines. The practicefocused question for this project was: Can the development of a CPG for aesthetic
providers increase their knowledge about delivering safe and consistent patient care?
By following the CPG, healthcare providers can provide safer care and help reduce or
prevent legal ramifications. In developing this CPG, concepts, models, and theories that
inform and support evidence are discussed in this section. I also synthesized primary
writings and clarified terms that may have multiple meanings pertaining to the CPG. This
section also includes a summary of local evidence and context of the problem and
relevance of the CPG to nursing practice. The role of the DNP student is also discussed.
Concepts, Models, and Theories
This CPG was developed using the AGREE II instrument, one of the most
commonly used guideline appraisal tools for CPG development and evaluation. In
developing this CPG, it was critical to analyze evidence in a review of literature and
grade such evidence accordingly. The evidence was graded using the MFRS of hierarchy
of evidence, which also allowed for prioritizing relevance of evidence in terms of the
development of the CPG. To support the successful implementation of the CPG, the
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theoretical domains framework (TDF) was included in the project and is also
recommended to help guide clinicians after this project has been completedwhen
implementing the changes. Implementation of this CPG using the TDF will support the
recommendations to assist in the facilitation of the CPG. The TDF encourages CPG
developers to analyze anticipated behavior changes of end-users to help determine how to
better apply or disseminate the CPG. With every change project, it is expected that some
level of resistance to change may exist, which further reinforces the importance of the
TDF in anticipating such change before implementation. While many researchers may
argue that common sense works just as well as theory when applying a CPG, more
relevant studies have suggested that CPGs that included a guided theory had a higher
chance of implementation success compared to those implemented without a guided
theory (Taylor et al., 2014).
AGREE II
The AGREE II instrument is quantitative and allows researchers to develop costeffective high quality CPGs. The AGREE II details various factors that comprise an
appropriate high-quality CPG. Researchers can use the AGREE II as a checklist to ensure
they have fulfilled requirements of guideline development, which involves scope and
purpose, stakeholder involvement, rigor or development, clarity of presentation,
applicability, and editorial independence (Seto et al., 2017). Regarding rigor, the AGREE
II details and evaluates systematic methods used to obtain evidence supporting the CPG
and evaluates whether or not the CPG was first reviewed by an expert panel prior to its
implementation or application to pilot studies (see Table 1).
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Table 1
Framework to Develop the CPG
AGREE II Model
Domain 1. Scope and Purpose
1. The overall objective(s) of the guideline is (are) specifically described.
2. The health question(s) covered by the guideline is (are) specifically
described.
3. The population (patient, public, etc.) to whom the guideline is meant to
apply is specifically described.
Domain 2. Stakeholder Involvement
4. The guideline development group includes individuals from all
relevant professional groups.
5. The views and preferences of the target population (patients, public,
etc.) have been sought.
6. The target users of the guideline are clearly defined.
Domain 3. Rigor of Development
7. Systematic methods were used to search for evidence.
8. The criteria for selecting the evidence are clearly described.
9. The strength and limitations of the body of evidence are clearly
described.
10. The methods for formulating the recommendations are clearly
described.
11. The health benefits, side effects, and risks have been considered in
formulating the recommendations.
12. There is an explicit link between the recommendations and the
supporting evidence.
13. The guideline has been externally reviewed by experts prior to its
publication.
14. A procedure for updating the guideline is provided.
Domain 4. Clarity of Presentation
15. The recommendations are specific and unambiguous
16. The different options for management of the condition or health issue
are clearly presented.
17. Key recommendations are easily identifiable.
Domain 5. Applicability
18. The guideline describes facilitators and barriers to its application.
19. The guideline provides advice and/or tools on how the
recommendations can be put into practice.
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20. The potential resource implications of applying the recommendations
have been considered.
21. The guideline presents monitoring and/or auditing criteria.
Domain 6. Editorial Independence
22. The views of the funding body have not influenced the content of the
guideline.
23. Competing interests of guideline development group members have
been recorded and addressed.
Note. From “Appraisal of Guidelines for Research and Evaluation II,” by The AGREE
Research Trust, 2013, pp. 6–8. Reprinted with permission.
MFRS Hierarchy of Evidence
Using the MFRS hierarchy of evidence, researchers are able to perform a rapid
critical appraisal of current evidence to determine level of evidence, quality of conducted
research, and usefulness to practice. In this project, a study evaluation table (see
Appendix A) was developed to divide hierarchy of evidence and answer applicable
questions. The MFRS was used to determine the appropriate level of evidence for every
resource used in the CPG development (see Table 2).
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Table 2
MFRS Rating System
Evidence Type

Level of Evidence

Systematic review or meta-analysis

Level I

Randomized controlled trial

Level II

Controlled trial without randomization

Level III

Case-control or cohort study
Systematic review of qualitative or
descriptive studies

Level IV
Level V
Level VI

Qualitative or descriptive study
Level VII
Expert opinion or consensus
Note. From “Evidence-Based Practice in Nursing and Health Care: A Guide to Best
Practice,” by Melnyk and Fineout-Overholt, 2011, p. 12. Reprinted with permission.
TDF
To help improve the successful development of the CPG, the TDF was applied
when teaching the expert panel about the content of the CPG and its significance. The
TDF was originally developed to evaluate influences on the behavior of medical
professionals going through change interventions in their specific organizations. When
attempting to change behavior, it is vital to understand and anticipate desired changes in
behavior (Atkins et al., 2017). Behavior scientists and researchers developed the TDF to
reduce unsuccessful implementation of change through a theoretical approach. Although
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this CPG has not yet been disseminated, it is expected that including the TDF enhanced
the CPG and its AGREE II rating by the expert panel.
Definition of Terms
Throughout this CPG project, multiple terms are used, some of which may also be
used interchangeably. Project terms defined:
Clinician: A healthcare individual who is licensed to provide medical aesthetic
treatments in their respective state.
Good faith exam (GFE): Initial medical history review and examination of a
patient that can only be performed by physicians or nonphysician providers.
Healthcare Provider: A healthcare individual who is licensed to provide medical
aesthetic treatments in their respective state.
Injector: A healthcare individual who is licensed to provide medical aesthetic
treatments in their respective state.
Med spa: A medical spa usually positioned outside of a traditional physician’s
medical office. It provides medical services and is owned and operated by a healthcare
provider licensed to practice medicine in their respective state.
Non-physician provider: Licensed nurse practitioners and physician assistants.
Mini GFE: Title given for the CPG form proposed for use by all injectors in
aesthetics prior to providing aesthetic treatments.
Nurse injector: RNs and NPs working in the aesthetic field.

15
Relevance to Nursing Practice
Existing Scholarship and Research
In synthesizing the literature, Rossi et al. (2019) said there were increased adverse
events involving nonsurgical cosmetic treatments performed by nonphysician providers
and RNs, as compared to physician providers. In the study survey, the most common
procedures received by participants included neuromodulator injections for wrinkles and
injectable dermal fillers, which are the top two procedures performed at the intended site
for this CPG project. Adverse events involving discoloration occurred at a greater rate
with nonphysician providers (43.5%; N = 23) compared to physician providers (14.8%; N
= 27). Dermal burns also occurred more frequently with nonphysician providers (34.8%)
compared to physician providers (7.4%). Providers in the aesthetic industry are aware
that dermal burns are possible side effects or complications from treatments such as
chemical peels, laser hair removal, intense pulse light (IPL), and other laser devices for
dermal treatments and not injectable neuromodulators and dermal fillers. Because dermal
burns are not likely to result from injectable treatments, the higher percentage of adverse
events from procedures as presented in Rossi et al. (2019) may not correlate to
procedures actually provided by nonphysician clinicians. Training and experience in such
procedures can significantly differentiate a good from a better injector. As it pertains to
this CPG, it is vital that RNs remain cognizant of state guidelines and contact physicians
if and when complications occur, which should be a standardized procedure and can be
incorporated as a practice standard.
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While collecting appropriate patient medical history before performing
nonsurgical aesthetic procedures is a responsibility of all injectors, that information, if
collected, is not being documented in the patient’s medical chart. This leads to lack of
proof that this examination was done. More importantly, the lack of documentation
leaves open the question of whether the best evidence-based patient care was performed.
While state boards of nursing across the nation agree regarding requirements and
documentation of GFEs for new clients entering a med spa, there seems to be a
generalized assumption in the aesthetic field that no further medical history review is
needed for up to 1 year for these patients. Hence, at the local site, only the initial GFE
evaluation is documented annually, regardless of the number of follow-up visits the client
may return to receive various cosmetic treatments thereafter. The patient is not asked
about his or her medical history, additional medications, or changes in skin before future
appointments after that annual GFE. From an added safety perspective, I found it
important to document that I reviewed patients’ medical history for any changes prior to
every patient visit. The CPG aims to address this consistent lack of documentation and
medical history review that appears to be occurring due to a lack of knowledge by
healthcare providers and administrative staff about the importance of documentation as
well as a lack of appropriate CPGs. Werschler et al. (2015) shared that if patients answer
yes to any dermatological conditions such as previous skin cancers, psoriasis, eczema, or
acne, that yes answer usually warrants further discussion with the patient to help prevent
complications associated with aesthetic procedures, particularly with the use of energybased devices.
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Current state guidelines leave many ambiguities in terms of interpretation, leaving
inexperienced injectors at risk of legal ramifications while reducing the safety of their
patients. Ann and Wicklin (2020) offered that respondents working in the field of
aesthetics rated a med spa to be more prone to adverse events than a traditional
physicians’ office. Of the respondents, 95.8% believed that regulations should be stricter,
while 84.3% admitted they would like more support and information from medical
societies related to medical spas.
Shallwani et al. (2019) said the use of the AGREE II instrument to appraise
current CPGs related to the benefits of physical activity in cancer patients was
instrumental in their study. Using the AGREE II to measure the quality of each domain in
their CPG, Shallwani et al. (2019) were able to identify that their CPG was lacking in the
domain of applicability. Using the AGREE II instrument, healthcare providers can also
identify where their CPGs maybe lacking to help improve overall patient outcomes and
quality of care.
Standard Practices Used by Accrediting Organizations
Vital to the medical spa industry is understanding the scope of practice of each
profession and tailoring policies and procedures to comply with those scopes of practices.
The MBOC and the CBON both operate under state guidelines that indicate the scope of
practice for nurses and physicians.
According to the California Nurse Practice Act (CNPA) Section 2725 (b, 4), in
providing nursing care or overlapping functions between physicians and RNs in
organized health care systems, the RN is responsible for: Observation of signs and
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symptoms of illness, reactions to treatment, general behavior, or general physical
condition, and determination of whether the signs, symptoms, reactions, behavior, or
general appearance exhibit abnormal characteristics, and implementation, based on
observed abnormalities, of appropriate reporting, or referral, or standardized procedures,
or changes in treatment regimen in accordance with standardized procedures, or the
initiation of emergency procedures (Nurse Practice Act, 2021).
The MBOC said that physician supervision is required when specific procedures
are being performed but does not clearly identify to what extent. Instead, the MBOC
requires that NPs and RNs operate under a formally written standardized procedure (SP)
agreement that is developed between the physician and the nurse, not the medical spa
institution. Both the MBOC (Title 16, CCR Section 1379) and the CBON (Title 16,
California Code of Regulations (CCR) section 1474) have jointly agreed on the
requirements for these SPs. Section 1474 (7) requires SPs to: “Specify the scope of
supervision required for performance of standardized procedure functions, for example,
telephone contact with the physician” (MBOC, 2020, p. 2). Furthermore, Section 1474
(2) requires the SPs to “Specify which standardized procedure functions registered nurses
may perform and under what circumstances” (MBOC, 2020, p.2).
Other Approaches Used For Medical Clearance
In further researching literature on safety protocols for aesthetic procedures, the
articles that exist refer specifically to the initial GFE with a total disregard to the
discussion of any future pre-procedure examinations, which confirms the significant gap
in the existing literature. More importantly, existing literature does not link the adverse
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events of nonsurgical procedures to the lack of pre-procedural health history
examination; however, the literature has linked these adverse events with surgical
procedures. Kim et al. (2015) argued that the majority of surgical adverse events are
directly related to errors occurring before or after the procedure and not during it.
Furthermore, Kim et al. (2015) emphasized that failures or breakdowns in
communication within and amongst the surgical team, patients, and their families were
key factors that may have been eliminated with pre-procedural health histories. Chhabra
et al. (2019) and Kim et al. (2015) said that interventions such as the World Health
Organization’s (WHO) pre-operative checklist and Reason’s Swiss Cheese Model
(RSCM) have helped prevent or reduce surgical adverse events. The WHO pre-operative
checklist focuses on four areas of improvement including safety, and the prevention of
surgical site infections. According to Chhabara et al. (2019) operating room employees
are given a checklist consisting of questions that guide the surgeon and assists staff on
what steps to take prior to anesthesia and skin incision, as well as after surgery. This CPG
also provides clinicians with a checklist to use prior to performing nonsurgical
treatments. Using the RSCM, accidents and mistakes in surgery were significantly
reduced as it helped prevent one error from becoming prolonged throughout the surgical
process. In short, a process is completed in a particular order before moving forward,
hence preventing errors from prematurely advancing in the process. This CPG also has
similar attributes to help limit the number of errors made by aesthetic providers in an
effort to standardize pre-procedure protocols. This CPG requires providers to answer
specific questions before they can move on to the next question.
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Advances to Nursing Practice
The CPG aligns with the American Association of Colleges of Nursing DNP
Essentials by advancing nursing practice, empowering nurses to provide evidence-based
practice, while ensuring patient safety of the highest level in the field of aesthetics
(Garritano et al., 2016). With implementation, the CPG aims to streamline and
standardize provider practice, improve patient safety, and reduce the legal ramifications
for injectors. The development of a CPG such as this by an NP can advance nursing
practice by providing a quality evidence-based project that can easily be implemented by
nurses and other providers practicing in the field of aesthetics. As more aesthetic patients
present to the local med spa with complaints of bleeding and bruising resulting from
aesthetic procedures, the CPG can guide current and future injectors on the steps
necessary to break the cycle of reviewing a patient’s medical history once per year but
rather review the medical history prior to every aesthetic procedure. The CPG requires
injectors to screen patients for medications and medical history that may place patients at
a higher risk of bleeding or bruising during aesthetic procedures.
Local Background and Context
It is important that injectors review and use the guidelines developed from other
specialties, which can be customized for the aesthetic nonsurgical field. To help improve
provider knowledge, improve patient outcomes and safety, and reduce adverse events, the
CPG helps to fill this gap in the literature and practice. Kim et al. (2015) believes that
while errors may always occur, as a change agent, it is essential to reinforce a change
such as the CPG to help eliminate the tolerance of unsafe practice and align providers
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with safer practices. At the local site, a once-yearly GFE is being performed and
documented by a physician or non-physician provider prior to a patient’s initial medical
treatment. The problem that exists at the local site is that providers are not performing a
review of the patient’s medical history prior to performing every aesthetic procedure.
Additionally, if an injector asks certain patient questions or performs a medical history
review prior to treatment, it was not being documented. A known practice reality is that a
patient’s medical history may change from one day to the next; hence, the reliance on a
once-yearly GFE by a health care provider may not be of value to a patient seeking
treatment throughout the year. More importantly, healthcare providers practicing
according to their respective licensures, would be assessing and evaluating the patient’s
medical history prior to each surgical and nonsurgical event to look for possible
contraindications to treatment. While multiple med spa settings could be practicing the
same bad habits, injectors could help break this cycle by implementing a practice
protocol or this CPG at their respective practice site. A review of a patient’s medical
history and pre-procedural instructions before a medical treatment has been shown to
reduce adverse events and side effects (Chhabra et al., 2019; Kim et al., 2015; Werschler
et al., 2015).
The estimated time it takes a clinician to perform a mini-GFE for a patient is
about 30-60 seconds, as long as no potential adverse contraindications were identified
needing further explanation. A significant component of the CPG requires clinicians to
document whether or not an initial GFE had ever been performed, which is mandated
nation-wide. Other steps in the CPG ensure that clinicians educate their patients about
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measures to reduce the risk of bleeding and bruising by avoiding certain commonly used
substances prior to their next appointment. The CPG will also include substances to
avoid, including non-steroidal anti-inflammatories (NSAIDs), alcohol, and some herbal
supplements like gingko biloba, folic acid, turmeric, and fish oil.
The local project site is a med spa located in the Western region of the United
States. The staff includes three medical assistants (MA), four receptionists, two NPs, one
PA, one general manager, one human resources manager, three RNs, and one medical
doctor (MD). Of the 16 employees, seven are licensed and able to provide aesthetic
medical treatments (RNs, NPs, & MD). Currently, none of these injectors use a written
CPG or similar protocol as a guide when providing medical treatments. At the project
site, the organization’s vision is to provide quality aesthetic procedures at affordable
prices that are less than the current average prices in the surrounding area. This vision is
geared towards giving individuals, who may not have otherwise had the finances, the
opportunity to obtain aesthetic procedures, alleviating the financial difference through
providing care to a higher volume of patients. The spa operates six days per week with an
average of nine hours per day. The organization services an average of about 100 patients
per week that present for medical aesthetic services.
Role of the DNP Student
As a DNP student, I served as the developer and project manager of this CPG. I
am a registered family nurse practitioner (FNP) with over 10 years of experience in the
healthcare field and 4 years of experience in nonsurgical aesthetic treatments. I received
my Bachelors in Science of Nursing (BSN) from Wayne State University in Detroit, MI
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in 2010 and my Master of Science in Nursing (MSN) from South University in Novi, MI
in 2016. I have extensive experience and hold certifications in performing many aesthetic
procedures such as laser treatments, the injections of dermal fillers, botulinum toxins,
platelet-rich plasma, deoxycholic acid, and many others for the treatment of fine lines,
wrinkles, fat pads, and volume loss. As an experienced leader in the field of aesthetic
services at the project site, I am aware of the need to standardize the treatment process for
aesthetic procedures. My experiences afforded me the ability to develop a CPG, and I
attained full support of the organization’s administrators, staff, and other end-users. I
moved from Detroit, Michigan in late 2018 to the Western region of the United States
primarily because of my passion and love for the field of aesthetic. My passion and
leadership position at the project site may be construed as a bias; however, that bias
affords me the opportunity to make positive social change in generating and translating
the much-needed evidence into practice, especially where patient outcomes and safety are
a concern. Compared to the Eastern part of the nation, the West provided a more
significant chance and opportunity to advance my aesthetic skills through exposure to the
latest and greatest in aesthetic devices and procedures in a rapidly growing field. This
experience has laid the foundation for my growth and reputation as an expert in aesthetic
procedures.
Summary
Having the reputation, credentials, and experience in aesthetic procedures further
supported my ability to recognize the existing practice gap and the need for this CPG.
Providers at the local project site continue to perform aesthetic procedures based on
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routine habits with limited information on safety and the respective state board
regulations. As a trusted tool in research and guideline development, the AGREE II tool
was used to evaluate the guideline from multiple perspectives. Developing this CPG has
helped improve the knowledge of injectors in aesthetics, which can translate to providing
safer treatments to patients. If implemented, the CPG can help standardize aesthetic
procedures, build cultural confidence in the improved safety protocols of aesthetic
treatments, and improve overall patient outcomes. Furthermore, the MFRS of hierarchy
of evidence was used to analyze and evaluate the latest evidence that was used in the
project in regard to relevance and strength. While there are existing guidelines for
surgical treatments, the nonsurgical field lacks evidence and guidelines that can be used
to support nonsurgical procedures. Hence, reviewing and analyzing surgical guidelines
influenced and assisted me in the development of this CPG for nonsurgical procedures.
Incorporating the mini GFE as a component of the CPG may also help build a trusting
relationship between the injector and the patient, especially when time is taken to explain
that the reason for the mini GFE is to ensure a higher level of safety before treatments. In
a very busy med spa such as the local project site, time is of the essence, but safety must
always come first, safety that the implementation of the CPG will significantly improve.
While the CPG is an adjunct guideline, it is not to be considered a replacement to the
initial GFE that is required to be completed by a physician or non-physician provider.
Further analysis and synthesis of evidence will be discussed to justify the need and
provide more comprehensive support for this CPG project and its application in practice.
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Section 3: Collection and Analysis of Evidence
Introduction
With the rapid growth and prevalence of nonsurgical aesthetic treatments, more
RNs than ever have made their career in the field of aesthetics. An increase in aesthetic
treatments has also facilitated the growth of various options, products, and machines that
are readily available at many local medical spas. While there is no unique governing
body or state board specific to aesthetics, RNs, NPs, and physicians must always practice
according to their respective licensing boards and guidelines.
Unfortunately, with the rapid growth of the aesthetic field, state and federal
guidelines continue to be lacking with respect to safety and scope of practice for aesthetic
injectors. Consequently, botched procedures and adverse events from such procedures are
also rising (AMSPA, 2018). In fact, the lack of supervision of medical treatments by
physicians, as well as lack of training of injectors, has been the primary cause of legal
ramifications due to adverse events for patients undergoing such treatments.
The purpose of this DNP project was to develop a CPG that would help improve
knowledge of aesthetic injectors and standardize the treatment process prior to providing
medical treatments for patients. Evidence-based CPGs have become a foundation in
research, bridging the gap between literature on best policy, local context, and patient
choice. Adatto and Byrd (2017) said that the Institute of Medicine (IOM) defined a CPG
as a recommendation tool to help practitioners in clinically based patient decision-making
after a systematic review of literature and evidence has been completed. Kredo et al.
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(2016) supports the purposes of CPGs to standardize variations in practice, help improve
measurable quality care, and reduce adverse events.
Practice-Focused Question
While patients’ medical history and preprocedural instructions may be reviewed
verbally at the local project site, the lack of formal documentation prior to procedures is
lacking. Injectors have become dependent on a once-yearly GFE, even though patients
may receive varying treatments throughout the year. More importantly, patients’ medical
history and active medications may change more often than annually, requiring further
investigation and review by the injector before each medical aesthetic treatment (De
Boulle & Heydenrych, 2015).
The practice-focused question for this project is: Can the development of a CPG
for aesthetic providers increase their knowledge about delivering safe and consistent
patient care? In reviewing the literature, evidence on protocols and guidelines particular
to nonsurgical aesthetic procedures was limited. However, evidence and guidelines exist
in the field of medical aesthetic surgery and dermatology, where such procedures are also
performed. The AMSPA has many published articles on rules, laws, and regulations
pertaining to nonsurgical aesthetic procedures. AMSPA (2018) has reported that liability
for physicians and nonphysician providers in aesthetics continues to rise as more
nonsurgical aesthetic procedures are developed. This CPG can help to improve care
outcomes and safety and reduces injectors’ liability by adding official documentation to
patients’ medical record that a mini GFE was documented prior to treatment.
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Sources of Evidence
My search for evidence revealed 205 related academic journal articles and
publications. Of these 205 articles, I selected 31 that aligned with the DNP project. I used
the following keywords in my search: AGREE II, best practice, clinical practice
guidelines, Melnyk and Fineout-Overholt rating system of hierarchy of evidence, theory
in aesthetics, rules and regulations, medical spas in California, lawsuits with med spas,
California med spa laws, California Board of Nursing, California Board of Medicine,
good-faith exam, trouble for med spas, patient safety, safety in aesthetics, aesthetic
dermatology, cosmetic dermatology, best practice, physician supervision, adverse events
in aesthetics, and medical procedures by nurses. Along with the Walden University
Library, the following databases were used: CINAHL, ERIC, PubMed, Medline, and
BioMed Central.
Evidence collected for this CPG project was appraised using the MFRS hierarchy
of evidence rating system. The evidence selected for this CPG was rated and organized in
Appendix A. In searching literature, only information that was evidence-based, recent,
and relevant to the CPG was chosen. Chosen literature involved lack of protocols and
regulations in the aesthetic field and prevalence of adverse events in med spas as well as
lack of guidelines. Furthermore, I also focused on addressing patient safety, prevalence of
adverse events due to aesthetic procedures, and trends involving why such adverse events
were occurring according to current literature.
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Evidence Generated for the Doctoral Project
In this section, I provide information about evidence that was generated for this
CPG project. This section includes information about participants, procedures, and
protections that supported the development of this evidence-based CPG.
Participants
Participants included an expert panel that consisted of individuals who have
extensive experience in the field of aesthetics practice. Their feedback was instrumental
during the final development of the CPG. This expert panel was made up of six members,
including one attending physician owner, one general manager, one PA, one NP, and two
RNs.
Procedures
The CPG was developed after the Walden University Institutional Review Board
(IRB) approved the project. After approval by the Walden University IRB (#06-23-211021061), the CPG was developed using the following steps:
•

Appraise evidence collected from the literature search.

•

Synthesize evidence.

•

Develop the guideline/recommendations.

•

Identify an expert panel.

•

The expert panel reviews the guideline using the AGREE II instrument to
validate the content.

•

The expert panel scores the AGREE II Instrument.

•

Revise the guideline based on recommendations.
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•

Identify groups of stakeholders and end users.

•

Present the revised guideline to end users, /key stakeholders, and /local
experts and discuss to validate content and ensure usability.

•

Develop a final report.

•

Disseminate the final report to key stakeholders.

The AGREE II model was used to develop this CPG for aesthetic procedures. The
CPG was presented to an expert panel for feedback with detailed instructions on its use.
To evaluate the CPG, the expert panel was asked to rate various items from each domain
of the AGREE II on a four-point scale: strongly agree (1), agree (2), disagree (3), and
strongly disagree (4). The expert panel members used the AGREE II questionnaire to
appraise the EBP guideline, using the AGREE II six quality domains (see Table 3).

30
Table 3
Questionnaire for the CPG Using the Six Domains of AGREE II
1
Strongly
Agree

2

3

Agree

Disagree

4
Strongly
Disagree

Domain 1: Scope & Purpose
The population (patient, public, etc.) to
whom the guideline is meant to apply is
specifically described.

¢

¢

¢

¢

Domain 2: Stakeholders’ Involvement
The target users of the guideline are clearly
defined.

¢

¢

¢

¢

Domain 3: Rigor of Development
Systematic methods were used to search for
evidence.

¢

¢

¢

¢

Domain 4: Clarity of Presentation
The recommendations are specific and
unambiguous.

¢

¢

¢

¢

Domain 5: Applicability
The guideline provides advice and/or tools
on how the recommendations can be put
into practice.

¢

¢

¢

¢

Domain 6: Editorial Independence
The views of the funding body have not
influenced the content of the guideline.

¢

¢

¢

¢

Note. From “AGREE II: Advancing Guideline Development, Reporting and Evaluation
in Healthcare,” by the AGREE Research Trust (2010). Reprinted with permission.
Protections
The development of this CPG involved searching and synthesizing evidence and
did not involve patients. An expert panel comprised of administrative personnel reviewed
and provided feedback and recommendations on the guideline. Based on
recommendations, the CPG was revised and finalized. Names of expert panel members
using the AGREE II tool questionnaire were not required to support the confidentiality of
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evaluation results from the expert panel members. The name of the CPG implementation
site was also not included in the final report. Permission to conduct this project was
obtained from the Walden University IRB (#06-23-21-1021061), and the IRB approval
criteria were maintained.
Analysis and Synthesis
The CPG was evaluated and graded using the AGREE II tool questionnaire (see
Table 3) after review by the expert panel. Each related article used to support the
development of this CPG was appraised and graded using the MFRS of hierarchy of
evidence and organized in a table (see Appendix A). Because of the limited availability
peer-reviewed articles on efficacy of safety protocols in the field of nonsurgical aesthetic
treatments, peer-reviewed articles involving the associated fields of dermatology and
cosmetic surgery were also used to support the CPG. The limited number of peerreviewed articles was one of the driving forces for the development of this CPG.
Information to support the development of this CPG was also garnered from professional
organizations and professional licensing boards. The development of the CPG, evaluation
by the expert panel, recommendations from the expert panel, and final CPG report are
discussed in Section 4.
Summary
To date, there is no CPG focused on standardizing care that can lead to enhancing
patient care outcomes and patient and provider safety that can be used to guide aesthetic
injectors prior to the delivery of nonsurgical aesthetic procedures. The development of
this evidence-based CPG is the first of its kind to provide guidance for injectors when
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performing aesthetic procedures. The CPG will help to fill this gap in practice and
available literature in the field of aesthetics. This project was presented to an expert panel
comprised of members who were experienced in the nonsurgical aesthetic field. Changes
to the CPG were made according to feedback from this panel.
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Section 4: Findings and Recommendations
Introduction
This doctoral project focused on establishing a CPG to improve provider
knowledge and practice, through providing guidance to aesthetic providers when
performing nonsurgical procedures. At the local practicum site, nurses and other aesthetic
providers lack evidence-based guidelines to help them review safety protocols before
performing aesthetic procedures for patients presenting to the clinic. To date, this project
serves as the first of its kind in the field of nonsurgical aesthetics, with a focus to help fill
the existing gap in literature and practice as an evidence-based safety-oriented practice
guideline to streamline aesthetic services. The lack of standardization in practice resulted
in the practice gap that led to undesired patient outcomes that resulted from aesthetic
procedures, which compromised patient safety and increased litigation risks for aesthetic
providers.
While annual GFEs are currently being performed at the practice site, there was
no documentation that aesthetic providers were screening and documenting reviews of
patients’ medical history before every aesthetic procedure after that initial GFE.
Reviewing patients’ medical history before any medical treatment helps reduce adverse
events and side effects of treatments (Chhabra et al., 2019; Kim et al., 2015). The
practice-focused question for this DNP project asked: Can the development of a CPG for
aesthetic providers increase their knowledge about delivering safe and consistent patient
care?
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The purpose of this project was to address the practice-focused question by
creating this evidence-based CPG to help guide nurses and other aesthetic injectors in
streamlining the screening process of patients before performing any aesthetic procedure.
The CPG can help improve provider knowledge while bridging the gap in practice and
improving patient safety. Kredo et al. (2016) supports the use of CPGs and shared that
CPGs had become a foundation in practice, helping to guide evidence-based policy.
Furthermore, literature highlighted the importance of such CPGs in standardizing
variations in practice while also helping to improve the quality of care.
Sources of Evidence and Analytical Strategies
Sources of evidence were obtained using online databases to search for problems
in the aesthetic field relating to lack of practice guidelines for aesthetic procedures. In
searching for evidence through the Walden University Library, CINAHL, ERIC,
PubMed, Medline, and Bio-MedCentral databases were used. I also focused on evidence
related to patient safety during aesthetic procedures and protocols for improving such
safety in the fields of dermatology and plastic surgery. Established safety measures from
the field of dermatology and plastic surgery were incorporated into this CPG. The
evidence I used in developing this guideline was appraised using the MFRS hierarchy of
evidence rating system. As previously identified, expert panel members were individually
educated about AGREE II criteria via a written introductory statement and instructions
(see Appendix B). A summary that included the purpose of the CPG was provided to the
expert panel. Of the six expert panel members, five were also end users.
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Findings and Implications
The expert panel evaluated the CPG using AGREE II evaluation survey criteria.
Based on their evaluation, survey responses from the expert panel revealed support for
the guideline and a high interest in instituting the guideline at the local practicum site.
The expert panel’s high evaluation scores of this CPG were due to the strength and
completeness of the project. Comments and suggestions made by some of the expert
panel members indicated the importance and need for such a project at the local
practicum site:
•

Domain 1 - Scope and Practice: All six reviewers strongly agreed that the
CPG accurately and clearly described the population for whom the
guideline is intended.

•

Domain 2 - Stakeholders’ Involvement: All six reviewers strongly agreed
that the CPG clearly defined the intended target users. The expert panel
included professionals involving all intended users of the CPG (two RNs,
one NP, one PA, and one MD) to ensure their involvement in the
development, review, and approval of this CPG.

•

Domain 3 - Rigor of Development: All six reviewers agreed that the CPG
was developed using systematic methods to search for incorporated
evidence. This confirmed the reviewers’ unified support of criteria used to
search for evidence.

•

Domain 4 - Clarity of Presentation: Five members of the expert panel
strongly agreed that components of the CPG were clearly presented, One
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reviewer disagreed and provided feedback that grammatical errors needed
to be revised. This recommendation was embraced and addressed. Future
researchers can modify expert panel information to clarify that grammar,
while not part of the evaluation process rating when using the AGREE II
questionnaire, was important to the guideline’s content and clarity and was
also appreciated. If grammatical issues impact the clarity of the CPG, the
CPG developer should be contacted immediately to resolve content
feedback.
•

Domain 5 - Applicability: Four out of six reviewers strongly agreed
regarding the applicability of the CPG. One reviewer added that the CPG
provides advice and tools on how recommendations can be put into
practice. One reviewer disagreed and provided feedback that grammatical
errors needed revision. This feedback was embraced and addressed like
noted in domain 4.

•

Domain 6 - Editorial Independence: All six reviewers strongly agreed that
there was no funding involved in this project; therefore, there was no
influence on the content of the CPG, and editorial independence was
maintained.

Table 4 includes the expert panel’s evaluation scores of this CPG based on
AGREE II evaluation criteria. Figure 1 shows a bar-graph representation of results.
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Table 4
Results of the AGREE II Questionnaire for EBP CPG Development
Domains

Strongly
Agree

Agree

Disagree

Strongly
Disagree

Domain 1: Scope &
Purpose

6

0

0

0

Domain 2: Stakeholders’
Involvement

6

0

0

0

Domain 3: Rigor of
Development

3

3

0

0

Domain 4: Clarity of
Presentation

5

0

1

0

Domain 5: Applicability

4

1

1

0

Domain 6: Editorial
Independence

5

1

0

0
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Figure 1
Visual Representation of Expert Panel Questionnaire Results
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Agree
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Disagree
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Unanticipated Outcomes
As a part of this DNP project, the CPG was developed with the intention to
implement it at the practicum site. However, due to limited time and the transition of the
practicum site’s method of documentation from paper charting to electronic charting via
electronic medical record (EMR) software, it was not possible to develop and implement
the guideline simultaneously. Nonetheless, project site administrators plan to implement
this CPG after the completion of this DNP project and in the near future.
Only one expert panel member rated Domains 4 and 5 as “Disagree” as shown in
Table 1 and commented that these domains “need grammatical revisions.” Statistically,
this evaluation response is considered an outlier compared to median results of the
evaluation by other expert panel members. This suggests that ratings on these two
domains were due to grammatical errors; there was no comment that the rating was based
on the content of the guideline in these domains. Grammar while not a criterion of the
AGREE II evaluation tool, is an expectation to support content and clarity. Nonetheless,
evaluation decisions by other panel members supported domains 4 and 5. After reviewing
the expert panel’s evaluation results, the CPG was reviewed and revised. All
recommended changes were made, including any that related to grammar that remained.
Due to the unanticipated outcome relating to grammar, changes to instructions provided
to future expert panel evaluators can be made regarding immediate notification of the
project leader about grammatical concerns, especially if the grammatical concerns impact
the clarity of the CPG’s content and clarity of content. The project leader’s contact
information should be highlighted as a part of the CPG’s instruction, as it was for this

40
CPG. Reiterating that panelists focus on content, structure, and clarity of information
presented in the CPG per the AGREE II tool as a part of instructions could also add
clarity to the evaluation process.
Individual Implications
More information is needed in the aesthetic field to help guide injectors. CPGs
such as this are needed to help inform healthcare provider practice. The project findings
align with this DNP project’s aim to support healthcare providers working in the aesthetic
field. The time it takes an individual injector to complete the mini GFE is about one
minute. This additional effort by injectors helps to improve their knowledge of the
patient’s medical history and possible contraindications to treatment, as well as patient
outcomes. Incorporating this CPG, which includes this additional mini GFE step, can
furnish providers with a safe evidence-based care protocol to use as a guide when
providing aesthetic treatments.
Community Implications
The literature stressed the association of lack of protocols available to aesthetic
providers and the impact on poor patient outcomes, resulting in increasing litigation risks.
Using the developed CPG, medical facilities offering nonsurgical medical aesthetic
treatments can benefit from incorporating a standardized care process that can provide a
safer approach to care for patients. Furthermore, incorporating this CPG can help
improve injector knowledge about practice safety and proper federal protocols, which can
improve patient outcomes and have a positive impact on the aesthetic community.
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Institutional Implications
There is a gap in proper and consistent clinical practice at the local project site,
including the lack of a CPG to support treatment administration and documentation. A
documented review of patients’ medical history prior to providing each aesthetic
treatment was not found in medical records. While medical records reflected that annual
GFEs were being documented, there was no guideline in place that required assessment
of patients’ medical history prior to each patient procedure. This CPG will help reduce
and/or eliminate that gap in practice to ensure that aesthetic providers deliver
standardized care that can result in safer patient care. Once the CPG is implemented, the
institution’s administrators can communicate changed and improved practice standards
that can increase level of safety for patients seeking care there.
System Implications
Nonsurgical aesthetic procedures such as neurotoxins and dermal fillers at med
spas are considered medical treatments, and as such, are regulated by state medical board
(MBOC, 2020). Individuals such as RNs and NPs must ensure that they are following
guidelines set by boards of nursing in their respective states, in addition to what particular
institutions may impose. Using the developed CPG, injectors can have a standardized
practice process requiring that GFEs are completed at least once annually, and mini GFEs
are completed prior to every subsequent procedure. Once the CPG is implemented at the
project site, the organization can incorporate this CPG at other partner med spas,
providing a system-wide practice standard.
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Implications for Positive Social Change
This CPG can serve as a system-wide standardized practice approach for the
project site, other associated sites, and aesthetic institutions nationally and globally. This
CPG can prevent aesthetic providers from experiencing unnecessary practice and
procedural issues that can result in the need to halt procedures and institute resolutions.
Standardized aesthetic treatments can help improve patient safety, reduce adverse events,
and improve patient outcomes. Positive social change can be achieved through the
application of a standardized practice protocol like this CPG at the project site systemwide, locally, nationally, and globally.
This CPG can also serve as a resource for other medical practices providing
aesthetic treatments. For those currently practicing or institutions currently offering care
in the field of aesthetic medicine without a CPG, it is my recommendation that a CPG be
incorporated to provide a safer and standardized approach to clinical practice that can
improve patient outcomes and reduce litigations. I recommend that individuals and
institutions conduct their research and consult an attorney familiar with med spa practices
prior to adopting and implementing this or any other CPG supporting aesthetic care.
Applying a standardized practice protocol like this or other CPGs can further enhance
positive social change by supporting aesthetic injectors and providing a safer approach to
aesthetic treatments.
Recommendations
It is the responsibility of each licensed professional (RN, NP, PA, MD, DO) to
ensure that they are following their respective state licensing board guidelines regardless
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of protocols that maybe imposed at any particular med spa agency. This CPG should not
be constituted as a replacement to any state regulations on the administration of
neurotoxins, dermal fillers, or any other medical aesthetic procedure. However, given the
evidence provided and rigor in developing this CPG, it is recommended that the project
site take advantage of incorporating a standard of care. This CPG, which is presented in
Appendix B, was developed as a standard of care for aesthetic procedures performed at
the project site. If instituted at the project site, I also recommend that this CPG be
reviewed at least annually to determine if revisions are needed to assure that the guideline
continues to meet the needs of the institution, its providers, and patients.
Strengths and Limitations of the Project
Strengths
This CPG was developed using current evidence-based literature to enhance its
rigor. An expert panel at the local practice site with many years of experience in the
aesthetic field evaluated the CPG using the six domains of the AGREE II guideline
evaluation tool. The evaluators provided primarily positive feedback in their evaluations.
Despite one member rating two domains as less than “agree”, the rest of the expert panel
rated the six domains as either “strongly agree” or “agree”, with the majority of responses
coinciding with “strongly agree” as presented earlier in Figure 1. Best related evidence
from the fields of medical aesthetic surgery and dermatology were used to help support
and develop a CPG that can improve patient outcomes and safety. Resources from the
AMSPA were also used to help clarify legal regulations and discussions involving the
performance of aesthetic procedures.
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Limitations
A significant limitation of this CPG was the lack of existing clinical guidelines in
the aesthetic medicine industry. Another limitation was the lack of published evidence in
the field of aesthetics to support this guideline. Because of the limited evidence available
in aesthetics, evidence was garnered from the fields of aesthetic surgery and dermatology.
The DNP project was limited as projects’ scope would not include the implementation of
the guideline and therefore would not include the measurable data that would arise from
the outcome of the guideline’s use and the benefit to the project site. Analysis of end-user
feedback could have proven useful in future clinical projects, in the development of
similar CPGs, and other practice sites. Issues with compliance and user and
administrative feedback could not be obtained without implementation, which is also a
limitation to this project. While guideline implementation was my original goal for this
project, time and other site constraints impaired such an achievement from happening.
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Section 5: Dissemination Plan
Although the literature supports significant advancements to nursing knowledge
through project developments such as CPGs, lack of dissemination of such CPGs has
contributed to the gap between available evidence-based literature and application in
clinical practice. Dissemination of CPGs can help fill that gap and increase the
prevalence of CPGs in practice. The final CPG will be disseminated to the expert panel
and other staff members during a lunch meeting at the practicum site to facilitate end-user
discussions with other interested parties prior to site implementation. Once implemented,
this CPG will also be incorporated into the organization’s standard procedures and
protocols manual that is available to all employees at any time for reference.
Another means of disseminating this DNP project is an oral presentation at the
Medical Spa Show 2022 hosted by the AMSPA. If approved for presentation, this venue
will lead to significant exposure of the CPG and DNP project to some of the world’s top
aesthetic injectors, as this show is a highly anticipated annual event. A link to this DNP
project will be provided to audience members as a resource for future review of the
project in more detail. This link will also provide the show and conference audience with
an opportunity to print and download the CPG for further review or incorporation into
their own aesthetic practices.
Disseminating this DNP project on social media can also help in filling the
clinical practice gap. One of the barriers to research implementation that has been
relevant in the literature is the lack of a dissemination venue that incorporates feedback
loops, or a way of allowing the targeted audience to express their thoughts on any given

46
project presentation. Social media outlets like Facebook and Instagram allow users to
engage in open communication through messages and videos. The CPG will be presented
on social media through a PowerPoint video presentation to encourage other aesthetic
providers to review and possibly incorporate into their own practices.
This evidence-based CPG can be disseminated to medical clinics that provide
nonsurgical aesthetic treatments such as neurotoxins and dermal fillers. Administrators
and providers can align the CPG to their respective state guidelines and institutional
policies. Although this CPG has incorporated information from regulatory agencies in the
state of California, it can be applied to medical spas in any state, regardless of state law,
as objectives include streamlining aesthetic services and improving patient outcomes.
Analysis of Self
Conducting a clinical practice project and DNP project findings provided me with
tools as a nursing scholar as well as advancing the fields of nursing and aesthetics. The
experiences I gained in the development of this DNP project allowed me to become more
knowledgeable about the process of change that included factors such as facilitators,
barriers, and the importance of stakeholder involvement. Developing this project also
allowed me to learn how to better work through organizational channels and reach and
identify the relevant audience when seeking support for a change project.
Searching and collecting best evidence and sources of evidence for this DNP
project posed a challenge due to the current lack of scholarly resources and relevant
information about nonsurgical aesthetic practices. As the aesthetic field continues to
evolve, more researchers, clinical project leaders, and innovators are needed to help
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develop evidence-based CPGs that provide up-to-date protocols. Another challenge was
researching laws and regulations which govern aesthetic treatments. To date, there
remains no regulatory body that specifically regulates nonsurgical aesthetic procedures.
Currently, nurses and other aesthetic professionals are dependent on vague guidelines,
word of mouth, and what is considered to be common practice when providing aesthetic
treatments. The future dissemination of this DNP project will help nurses and other
aesthetic providers by addressing the importance of being informed, proper training, and
providing standardized care when performing aesthetic procedures.
Over the past 4 years, I have had the privilege of working at multiple medical spa
clinics in Michigan and California. I have also had the privilege of training with some of
the nation’s top aesthetic providers, constantly advancing my injection techniques for
improved patient outcomes and safety. Working for a growing organization has further
contributed to my growth as an aesthetic provider because of the value the organization
places on growth and development.
After the DNP project is approved and implemented at the project site and my
DNP degree from Walden University has been conferred, I plan to further advance my
position with my current employer becoming the head of the aesthetics department
responsible for overseeing and training novice injectors. As the head of the aesthetics
department, my responsibilities would be to develop policies, procedures, and CPGs, as
well as train other injectors about various aesthetic procedures. Supervisory duties also
include evaluating aesthetic injectors’ performance to ensure proper safety protocols are
being followed. As part of my long-term professional goals, I strive to become a public
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figure on social media, advocating for safe and consistent treatment and educating other
aesthetic providers.
Summary
This DNP project involved developing an evidence-based CPG to fill the gap in
practice related to the lack of a CPG for aesthetic injectors at the project site. This CPG
provides a streamlined approach when screening patients presenting for nonsurgical
aesthetic procedures that can be applied at the project site and other medical facilities that
offer nonsurgical aesthetic procedures. The CPG also serves as a simple yet effective tool
to assist aesthetic injectors in following a standardized practice guide, which incorporates
state and regulatory guidelines that can improve patient outcomes. This CPG can
empower new and novice aesthetic injectors to become more knowledgeable about
standard rules and regulations of providing safe and standardized nonsurgical aesthetic
treatments with an aim to improve patient safety that can serve to reduce legal
ramifications.
Implementation of this CPG at a practice site will help standardize patients’
documentation and screening processes prior to nonsurgical aesthetic procedures. CPGs
such as this have become a standard in clinical practice. By applying this or another
evidence-based CPG at their respective practice sites, nurses and other aesthetic
professionals can help to streamline the implementation of aesthetic procedures, improve
patient outcomes, and positively impact social change.
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Appendix B: Medical Spas: Ensuring Compliance and Patient Safety
Objectives:
1. Standardize the Medical Spa treatment processes.
2. Increase aesthetic injector knowledge and treatment practices about care standards
on providing medical treatments for patients.
3. To enhance treatment compliance and patient safety.
Problem Statement -Can the development of a clinical practice guideline (CPG) for
aesthetic providers increase their knowledge about delivering safe and consistent patient
care?
Target Population - Aesthetic injectors employed (Registered Nurses (RNs), Nurse
Practitioners (NPs), Physician Assistants (PAs), and Medical Doctors (MDs).
Guideline Monitoring -The medical assistant is currently responsible for ensuring that
all necessary patient forms are completed prior to beginning treatment such as patient
consent forms and arbitration agreements. This will be a continuous process, as the
injector assistant will ensure that the injector for every patient’s physical chart has
completed the CPG questionnaire before filing it. Monthly reviews of charts by the MD
of the practice will ensure continuous monitoring of guideline compliance.
Introduction
As advancements in nonsurgical medical aesthetics procedures continue to evolve, state
and federal policies providing clear, up to date, safety and legal guidelines for such
procedures performed at medical spas are limited or lacking. The terms physician and
MD are used interchangeably in this guideline. The terms NP, PA and non-physician
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providers are also used interchangeably in this guideline. As more people come forward
with complications resulting from nonsurgical procedures performed by improperly
trained providers, state regulatory agencies have begun to increase enforcement of state
guidelines violations (AMSPA, 2018). Goldberg (208) said that many medical spas and
operators that have faced legal ramifications were due to a lack of proper supervision of
medical treatments as well as improperly trained personnel. Non-compliance with state
and federal laws and professional scope of practice, compromise patient safety, impact
patient outcomes, and increase the potential for litigation.
Part I – Initial Good Faith Exam (GFE)
An initial GFE must be conducted on each patient once they present for services during
their first visit. The patient must have an initial GFE completed and documented by a
physician or a non-physician provider within the last 365 days for the followup GFE
(mini GFE) to be initiated. The initial GFE must be documented and completed per
existing organization protocol at least every 365 days.
Part II – Follow up Good Faith Exam (mini GFE)
The mini GFE evaluation form is to be completed for every patient visit by the injector
prior to the administration of any aesthetic medical treatment. This mini GFE evaluation
applies only to patients who have had an initial GFE performed in the last 365 days.
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Clinical Practice Guideline: Improvement of Injector Knowledge and Patient Safety
1. Has the patient had a GFE performed in the last
year?

YES: ¢

: Continue to the next question.

NO: ¢

: Stop here and perform a GFE per your

organization protocol.

2. Does the patient have any bleeding disorders or

YES: ¢

: Please advise the patient on the

has the patient taken (NSAIDS), aspirin-

increased risks for bleeding, bruising, and skin

containing products, or herbal supplements

sensitivities that may occur during procedure. Give

(ginkgo biloba, folic acid, turmeric, melatonin,

the patient the options to continue with treatment or

garlic, coenzyme Q, cayenne, kava kava, ginger,

to reschedule the service.

etc.) in the last 7 days?

NO: ¢

: Continue to the next question.

YES: ¢

: If there are questionable

3. Has the patient had any changes in their medical
history since the last good faith exam, particularly

contraindications, please contact the physician or

any new skin conditions or other conditions that

non-physician provider to discuss and clarify

may deem to be contraindicated by the injector?

concerns prior to performing the treatment.
NO: ¢

: Continue to the next question

4. Has the patient reviewed, signed, and understands

YES: ¢

all the pre and post-procedure instructions given

NO: ¢

to them for the treatment being performed today?

instructions with patient for clarity.

Provider Signature:

_____________________

Date:

: Please review pre and post-procedure

_____________________________
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Med Spa Compliance
and Safety Guideline
Components
(Collected from the
evidence/literature)

Recommendation

Level of
Evidence/Quality
Ratings
(Melnyk &
FineoutOverholt’s
hierarchy of
evidence rating
system)
VII / Poor

Part I: Ensure a GFE
has been performed. If
a GFE has not been
performed, the injector
must then ensure that a
GFE is performed
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organization guidelines.

Always ensure that a
GFE has been
performed within 365
days prior to
providing any
medical treatment.

Part II: Does the patient
have any bleeding
disorders and or has
taken (non-steroidal
anti-inflammatory
drugs, aspirin
containing products,
and or herbal
supplements (ginkgo
biloba, folic acid,
turmeric, melatonin,
garlic, coenzyme Q,
cayenne, kava kava,
ginger, etc.) in the last
7 days?

If the answer is YES,
Please advise the
patient on the
increased risks for
bleeding, bruising,
and or skin
sensitivities that may
occur during
procedure. Give the
patient the option to
continue with
treatment or to
reschedule.

VI / Fair

Has the patient had any
changes in their
medical history since
the last good faith

If the answer is YES,
and if there are
questionable
contraindications,

IV / Good

Comments

Source of
Evidence
(Identify
Specific
literature)

The Medical
Board of
California
(MBOC) and
California
Board of
Nursing
(CBON)
require that an
initial good
faith exam
(GFE) be
performed and
documented
by a physician
or an APRN.
Importance of
medical
history review
to help
improve
patient safety
and prevent
adverse events
from cosmetic
treatments.
Authors
discussed
medications
that may be
contraindicate
d if taken
before
cosmetic
dermal fillers.
An
observational
study that
stressed the

American Med
Spa
Association
(2018)

Clinical,
Cosmetic and
Investigational
Dermatology
(2015)

Nigerian
Journal of
Surgery
(2019)
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exam, particularly any
new skin conditions or
other conditions that
may deem to be
contraindicated by the
injector?

please contact the
physician or nonphysician provider to
discuss prior to
performing the
treatment.

Has the patient
reviewed, signed, and
understands all the pre
and post instructions
given to them for the
treatment being
performed today?

If the answer is NO,
please review pre and
post-procedure
instructions with
patient for clarity.

VII / Poor

importance of
reviewing a
patient’s
medical
history and
safety
checklist prior
to surgery to
help reduce
adverse
events.
Concluded
that most
adverse events
occurred
because of
errors that
were
overlooked
prior to or
after surgery.
Expert
knowledge on
the prevention
and treatment
of the number
one adverse
event of
cosmetic
treatments,
bruising. The
authors
support the
need for pretreatment
evaluations
and review of
medical
history to help
prevent
adverse
events.

The Journal of
Clinical and
Aesthetic
Dermatology
(2017)
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Rationale Supporting Guideline Questions: Why should we ask these questions?
Question 1: Has the patient had a GFE performed in the last year? If the answer is
“Yes”, then the injector can continue with the CPG while if the answer is “No”, the
injector will discontinue the CPG and request that the annual GFE with a physician or
non-physician provider be performed with the patient prior to initiating any medical
treatment. At the local practicum site, there have been many incidences where an injector
would forget to check a patient’s file to ensure that a GFE had been previously done and
if within the past 365 days. The patient would leave the clinic after receiving a medical
treatment, many times performed by an RN. If a nurse injector performs medical
treatments without standing orders from a physician or non-physician provider, the nurse
could be in violation of both state and federal guidelines for the unlawful practice of
medicine (CBON, 2013). For many reasons, this can put the injector’s license at risk
while leaving the nurse, the medical director, and the med spa organization, open for
litigation and impact patient outcomes (AMSPA, 2018).
Question 2: Does the patient have any bleeding disorders and/or has taken nonsteroidal anti-inflammatory (NSAIDS) (ibuprofen, Motrin, Advil, Aleve), aspirin
containing products, and or herbal supplements (ginkgo biloba, folic acid, turmeric,
melatonin, garlic, coenzyme Q, cayenne, kava kava, ginger, etc.) in the last 7 days? If the
answer is “Yes”, the injector is to educate the patient on this risk and a joint decision
between the patient and the provider is made if the patient would like to continue with the
procedure or to re-schedule. If the patient has consumed any of these medications within
the past 7 days, the procedure can be performed; however, the patient must be informed
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that they are at increased risk of possible bruising and or bleeding during the procedure
and should be provided the option of re-scheduling their procedure. The use of such
products prior to nonsurgical cosmetic treatments has been shown to increase the
prevalence of bleeding and contusions during and after treatment. In fact, bruising has
been noted as the most common adverse event from dermal filler and botulinum toxin
injections. Results showing the prevalence of bruising after such treatments have ranged
from 19% to as high as 68% and can last for longer than two weeks. The number one
complaint from patient dissatisfaction has been extensive bruising (King, 2017).
Question 3: Has the patient had any changes in their medical history since the last
good faith exam, particularly any new skin conditions or other conditions that may deem
to be contraindicated by the injector? If the answer is “Yes”, the injector will decide
whether or not a contraindication exists. If the injector is an RN and there is questionable
doubt of possible contraindications, he or she must initiate a telephone consult with the
physician or non-physician provider prior to the treatment. Reaching out to the physician
or non-physician provider for further evaluation of the patient’s medical changes will
ensure that the RN is practicing within his/her scope of practice (CBON, 2013).
Question 4: Has the patient reviewed, signed, and indicated understanding of all
the pre and post procedure instructions given to him/her for the treatment being
performed today? If the answer is “No”, it is recommended that these instructions be
discussed with the patient prior to administering any treatment so that all questions and
concerns are addressed. It is a standard of practice for patients to sign consent forms for
treatments as well as sign pre and post-procedure instructions to ensure that any questions
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or concerns are addressed prior to the treatment. At the project site, unfortunately these
forms are signed for all available treatments from the date of the patient’s initial GFE and
are not routinely reviewed with the patient prior to any and all of the scheduled
treatments thereafter. The American Med Spa Association (AMSPA), reports that 37% of
respondents to a survey related to the GFE admitted either the GFE wasn't being
performed or, that the physician, PA, or NP was not the one performing the initial exam
(Adatto & Byrd, 2017). Prior to administering any medical treatment to a patient, the
CPG will provide a guideline-directed process that includes steps for the injector to
follow, helping to improve injector knowledge, patient safety, and the prevention of
adverse events.
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Appendix C: Expert Panel Evaluation
Thank you for your participation in the evaluation of this clinical practice
guideline (CPG). Your feedback is critical to the success and further development of this
CPG. Please fill out the following questionnaire by choosing one rating for each of the
six domains listed below ranging from strongly agree to strongly disagree.
Questionnaire for the CPG Using the 6 Domains of the AGREE II
1
Strongly
Agree

2

3

Agree

Disagree

4
Strongly
Disagree

Domain 1: Scope & Purpose
The population (patient, public, etc.) to
whom the guideline is meant to apply is
specifically described.

¢

¢

¢

¢

Domain 2: Stakeholders’ Involvement
The target users of the guideline are clearly
defined.

¢

¢

¢

¢

Domain 3: Rigor of Development
Systematic methods were used to search for
evidence.

¢

¢

¢

¢

Domain 4: Clarity of Presentation
The recommendations are specific and
unambiguous

¢

¢

¢

¢

Domain 5: Applicability
The guideline provides advice and/or tools
on how the recommendations can be put
into practice.

¢

¢

¢

¢

Domain 6: Editorial Independence
The views of the funding body have not
influenced the content of the guideline.

¢

¢

¢

¢

Note. From “AGREE II: Advancing Guideline Development, Reporting and Evaluation
in Healthcare,” by the AGREE Research Trust (2010). Reprinted with permission.
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